Literature DB >> 17377415

Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.

Anne Juuti1, Johan Lundin, Stig Nordling, Johanna Louhimo, Caj Haglund.   

Abstract

OBJECTIVE: Matrix metalloproteinases (MMPs) degrade extracellular matrix and are involved in tumor invasion and metastasis in various cancers. In pancreatic cancer, MMP-2 expression is upregulated and correlates with tumor recurrence. The aim of this study was to evaluate the prognostic significance of MMP-2 in pancreatic ductal adenocarcinoma.
METHODS: MMP-2 expression was assessed by immunohistochemistry in 127 patients operated on at Helsinki University Hospital from 1974 to 1998, with expression interpreted separately in epithelial and stromal samples.
RESULTS: Epithelial MMP-2 expression was strong in 5%, moderate in 20%, weak in 25% and negative in 50% of the tumors, with high epithelial MMP-2 expression significantly associated in univariate survival analysis with advanced stage, poor grade and poor survival. Stromal MMP-2 expression was strong in 0%, moderate in 14%, weak in 70% and negative in 16% of the cases, and did not significantly correlate with patient survival.
CONCLUSION: Epithelial MMP-2 correlates with advanced tumor stage and grade, but is not an independent predictor of survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377415     DOI: 10.1159/000100988

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  11 in total

1.  The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion.

Authors:  Kristopher R Koch; Chen-Ou Zhang; Piotr Kaczmarek; Joseph Barchi; Li Guo; Hanief M Shahjee; Susan Keay
Journal:  Invest New Drugs       Date:  2011-09-20       Impact factor: 3.850

2.  Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway.

Authors:  Jin Zhou; Zi-Xiang Zhang; De-Chun Li
Journal:  Curr Ther Res Clin Exp       Date:  2010-08

3.  S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.

Authors:  Fengjin Qin; Yao Song; Zijian Li; Ling Zhao; Youyi Zhang; Li Geng
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

Review 4.  Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Wilson Petrushnko; Justin S Gundara; Philip R De Reuver; Greg O'Grady; Jaswinder S Samra; Anubhav Mittal
Journal:  HPB (Oxford)       Date:  2016-07-14       Impact factor: 3.647

5.  Effect of DAPK1 gene on proliferation, migration, and invasion of carcinoma of pancreas BxPC-3 cell line.

Authors:  Yong Qin; Guan-Xiong Ye; Cheng-Jun Wu; Shi Wang; De-Biao Pan; Jin-Yan Jiang; Jing Fu; Sheng-Qian Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  The molecular targets for the diagnosis and treatment of pancreatic cancer.

Authors:  Alexios S Strimpakos; Kostas N Syrigos; Muhammad Wasif Saif
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

Review 7.  Molecular imaging in cancer treatment.

Authors:  Mark H Michalski; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

Review 8.  Molecular imaging for cancer diagnosis and surgery.

Authors:  Timon Hussain; Quyen T Nguyen
Journal:  Adv Drug Deliv Rev       Date:  2013-09-22       Impact factor: 15.470

9.  Matrix metalloproteinases 2 and 9 immunoexpression in prostate carcinoma at the positive margin of radical prostatectomy specimens.

Authors:  Romano Oguić; Vladimir Mozetič; Eleonora Cini Tešar; Dora Fučkar Čupić; Elvira Mustać; Gordana Dorđević
Journal:  Patholog Res Int       Date:  2014-07-06

10.  Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft.

Authors:  Jian-Hua Yin; Xiao-Yan Zhu; Wei-Dong Shi; Lu-Ming Liu
Journal:  BMC Complement Altern Med       Date:  2014-12-13       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.